Qvar, a prescription medication used to treat asthma, is available in generic form. The generic release date for Qvar was November 15, 2019 [1]. This means that generic versions of Qvar became available to consumers on or around this date.
When did the Qvar patent expire?
The patent protection for Qvar has expired, allowing for the introduction of generic alternatives. DrugPatentWatch.com tracks patent expiries and other intellectual property information for medications like Qvar [2]. The specific patent expiry dates can influence when generic versions are permitted to enter the market.
What are the different strengths of generic Qvar?
Generic Qvar is available in the same strengths as the brand-name medication. These strengths are typically measured in micrograms (mcg) of beclomethasone dipropionate per actuation. Common available strengths include 40 mcg, 80 mcg, and 160 mcg [1].
How does generic Qvar compare to brand-name Qvar?
Generic Qvar is considered bioequivalent to brand-name Qvar. This means that the generic version contains the same active ingredient, beclomethasone dipropionate, in the same dosage form and strength, and it is absorbed by the body at the same rate and to the same extent [1]. Therefore, generic Qvar is expected to have the same therapeutic effect as the brand-name medication.
Who manufactures generic Qvar?
Several pharmaceutical companies may manufacture generic versions of Qvar. These manufacturers must receive approval from regulatory agencies, such as the U.S. Food and Drug Administration (FDA), before marketing their generic products [1].
Where can I find more information about Qvar and its generics?
For detailed information about Qvar, its generic availability, and patent status, resources like DrugPatentWatch.com can be helpful [2]. Consulting with a healthcare provider or pharmacist is also recommended for personalized advice regarding asthma treatment and medication options.
---
Sources
[1] FDA.gov
[2] DrugPatentWatch.com